Armstrong Sarah, Bhide Priya, Jordan Vanessa, Pacey Allan, Farquhar Cindy
Department of Oncology & Metabolism, University of Sheffield, Academic Unit of Reproductive and Developmental Medicine, Level 4, The Jessop Wing, Sheffield, UK, S10 2SF.
Cochrane Database Syst Rev. 2018 May 25;5(5):CD011320. doi: 10.1002/14651858.CD011320.pub3.
Embryo incubation and assessment is a vital step in assisted reproductive technology (ART). Traditionally, embryo assessment has been achieved by removing embryos from a conventional incubator daily for quality assessment by an embryologist, under a light microscope. Over recent years time-lapse systems have been developed which can take digital images of embryos at frequent time intervals. This allows embryologists, with or without the assistance of embryo selection software, to assess the quality of the embryos without physically removing them from the incubator.The potential advantages of a time-lapse system (TLS) include the ability to maintain a stable culture environment, therefore limiting the exposure of embryos to changes in gas composition, temperature and movement. A TLS has the potential advantage of improving embryo selection for ART treatment by utilising additional information gained through continuously monitoring embryo development. Use of a TLS often adds significant extra cost onto an in vitro fertilisation (IVF) cycle.
To determine the effect of a TLS compared to conventional embryo incubation and assessment on clinical outcomes in couples undergoing ART.
We used standard methodology recommended by Cochrane. We searched the Cochrane Gynaecology and Fertility (CGF) Group trials register, CENTRAL, MEDLINE, Embase, CINAHL and two trials registers on 2 August 2017.
We included randomised controlled trials (RCTs) in the following comparisons: comparing a TLS, with or without embryo selection software, versus conventional incubation with morphological assessment; and TLS with embryo selection software versus TLS without embryo selection software among couples undergoing ART.
We used standard methodological procedures recommended by Cochrane. The primary review outcomes were live birth, miscarriage and stillbirth. Secondary outcomes were clinical pregnancy and cumulative clinical pregnancy. We reported quality of the evidence for important outcomes using GRADE methodology. We made the following comparisons.TLS with conventional morphological assessment of still TLS images versus conventional incubation and assessmentTLS utilising embryo selection software versus TLS with conventional morphological assessment of still TLS images TLS utilising embryo selection software versus conventional incubation and assessment MAIN RESULTS: We included eight RCTs (N = 2303 women). The quality of the evidence ranged from very low to moderate. The main limitations were imprecision and risk of bias associated with lack of blinding of participants and researchers, and indirectness secondary to significant heterogeneity between interventions in some studies. There were no data on cumulative clinical pregnancy.TLS with conventional morphological assessment of still TLS images versus conventional incubation and assessmentThere is no evidence of a difference between the interventions in terms of live birth rates (odds ratio (OR) 0.73, 95% CI 0.47 to 1.13, 2 RCTs, N = 440, I = 11% , moderate-quality evidence) and may also be no evidence of difference in miscarriage rates (OR 2.25, 95% CI 0.84 to 6.02, 2 RCTs, N = 440, I = 44%, low-quality evidence). The evidence suggests that if the live birth rate associated with conventional incubation and assessment is 33%, the rate with use of TLS with conventional morphological assessment of still TLS images is between 19% and 36%; and that if the miscarriage rate with conventional incubation is 3%, the rate associated with conventional morphological assessment of still TLS images would be between 3% and 18%. There is no evidence of a difference between the interventions in the stillbirth rate (OR 1.00, 95% CI 0.13 to 7.49, 1 RCT, N = 76, low-quality evidence). There is no evidence of a difference between the interventions in clinical pregnancy rates (OR 0.88, 95% CI 0.58 to 1.33, 3 RCTs, N = 489, I = 0%, moderate-quality evidence).TLS utilising embryo selection software versus TLS with conventional morphological assessment of still TLS imagesNo data were available on live birth or stillbirth. We are uncertain whether TLS utilising embryo selection software influences miscarriage rates (OR 1.39, 95% CI 0.64 to 3.01, 2 RCTs, N = 463, I = 0%, very low-quality evidence) and there may be no difference in clinical pregnancy rates (OR 0.97, 95% CI 0.67 to 1.42, 2 RCTs, N = 463, I = 0%, low-quality evidence). The evidence suggests that if the miscarriage rate associated with assessment of still TLS images is 5%, the rate with embryo selection software would be between 3% and 14%.TLS utilising embryo selection software versus conventional incubation and assessmentThere is no evidence of a difference between TLS utilising embryo selection software and conventional incubation improving live birth rates (OR 1.21, 95% CI 0.96 to 1.54, 2 RCTs, N = 1017, I = 0%, very low-quality evidence). We are uncertain whether TLS influences miscarriage rates (OR 0.73, 95% CI 0.49 to 1.08, 3 RCTs, N = 1351, I = 0%, very low-quality evidence). The evidence suggests that if the live birth rate associated with no TLS is 38%, the rate with use of conventional incubation would be between 36% and 58%, and that if miscarriage rate with conventional incubation is 9%, the rate associated with TLS would be between 4% and 10%. No data on stillbirths were available. It was uncertain whether the intervention influenced clinical pregnancy rates (OR 1.17, 95% CI 0.94 to 1.45, 3 RCTs, N = 1351, I = 42%, very low-quality evidence).
AUTHORS' CONCLUSIONS: There is insufficient evidence of differences in live birth, miscarriage, stillbirth or clinical pregnancy to choose between TLS, with or without embryo selection software, and conventional incubation. The studies were at high risk of bias for randomisation and allocation concealment, the result should be interpreted with extreme caution.
胚胎培养与评估是辅助生殖技术(ART)中的关键步骤。传统上,胚胎评估是通过每天将胚胎从传统培养箱中取出,由胚胎学家在光学显微镜下进行质量评估。近年来,延时摄影系统得以开发,它能够以频繁的时间间隔对胚胎进行数字成像。这使得胚胎学家无论有无胚胎选择软件的辅助,都能在不将胚胎从培养箱中取出的情况下评估其质量。延时摄影系统(TLS)的潜在优势包括能够维持稳定的培养环境,从而限制胚胎暴露于气体成分、温度和移动的变化中。TLS具有通过利用持续监测胚胎发育所获得的额外信息来改善ART治疗中胚胎选择的潜在优势。使用TLS通常会给体外受精(IVF)周期增加显著的额外成本。
确定与传统胚胎培养和评估相比,TLS对接受ART的夫妇临床结局的影响。
我们采用了Cochrane推荐的标准方法。于2017年8月2日检索了Cochrane妇科与生育(CGF)组试验注册库、CENTRAL、MEDLINE、Embase、CINAHL以及两个试验注册库。
我们纳入了以下比较的随机对照试验(RCT):比较有或无胚胎选择软件的TLS与采用形态学评估的传统培养;以及在接受ART的夫妇中,有胚胎选择软件的TLS与无胚胎选择软件的TLS。
我们采用了Cochrane推荐的标准方法程序。主要综述结局为活产、流产和死产。次要结局为临床妊娠和累积临床妊娠。我们使用GRADE方法报告重要结局的证据质量。我们进行了以下比较。
有或无胚胎选择软件的TLS与传统形态学评估的TLS图像与传统培养和评估
使用胚胎选择软件的TLS与传统形态学评估的TLS图像的TLS
使用胚胎选择软件的TLS与传统培养和评估
我们纳入了8项RCT(N = 2303名女性)。证据质量从极低到中等不等。主要局限性在于不精确性以及与参与者和研究人员缺乏盲法相关的偏倚风险,以及一些研究中干预措施之间显著异质性导致的间接性。没有关于累积临床妊娠的数据。
有或无胚胎选择软件的TLS与传统形态学评估的TLS图像与传统培养和评估
在活产率方面,干预措施之间没有差异的证据(优势比(OR)0.73,95%置信区间0.47至1.13,2项RCT,N = 440,I² = 11%,中等质量证据),流产率方面也可能没有差异的证据(OR 2.25,95%置信区间0.84至6.02,2项RCT,N = 440,I² = 44%,低质量证据)。证据表明,如果与传统培养和评估相关的活产率为33%,使用对TLS图像进行传统形态学评估的TLS时的活产率在19%至36%之间;如果传统培养的流产率为3%,与对TLS图像进行传统形态学评估相关的流产率在3%至18%之间。在死产率方面,干预措施之间没有差异的证据(OR 1.00,95%置信区间0.13至7.49,1项RCT,N = 76,低质量证据)。在临床妊娠率方面,干预措施之间没有差异的证据(OR 0.88,95%置信区间0.58至1.33,3项RCT,N = 489,I² = 0%,中等质量证据)。
使用胚胎选择软件的TLS与传统形态学评估的TLS图像的TLS
没有关于活产或死产的数据。我们不确定使用胚胎选择软件的TLS是否会影响流产率(OR 1.39,95%置信区间0.64至3.01,2项RCT,N = 463,I² = 0%,极低质量证据),临床妊娠率可能也没有差异(OR 0.97,95%置信区间0.67至1.42,2项RCT,N = 463,I² = 0%,低质量证据)。证据表明,如果与评估TLS图像相关的流产率为5%,使用胚胎选择软件时的流产率在3%至14%之间。
使用胚胎选择软件的TLS与传统培养和评估
没有证据表明使用胚胎选择软件的TLS与传统培养在提高活产率方面存在差异(OR 1.21,95%置信区间0.96至1.54,2项RCT,N = 1017,I² = 0%,极低质量证据)。我们不确定TLS是否会影响流产率(OR 0.73,95%置信区间0.49至1.08,3项RCT,N = 1351,I² = 0%,极低质量证据)。证据表明,如果不使用TLS时的活产率为38%,使用传统培养时的活产率在36%至58%之间;如果传统培养的流产率为9%时,与TLS相关的流产率在4%至10%之间。没有关于死产的数据。不确定该干预措施是否会影响临床妊娠率(OR 1.17,95%置信区间0.94至1.45,3项RCT,N = 1351,I² = 42%)。
在有或无胚胎选择软件的TLS与传统培养之间,在活产、流产、死产或临床妊娠方面是否存在差异,证据不足。这些研究在随机化和分配隐藏方面存在较高的偏倚风险,结果应极其谨慎地解释。